2026-W46 · Nov 9–Nov 15 · Company · Profile · published
Veeva Systems Inc. company profile · business segments · history · financial snapshot · S&P 500 rank #231 · Veeva公司業務歷史財務與標普500地位
SNAPSHOT
| Ticker | VEEV |
| Company | Veeva Systems Inc. |
| GICS sector / industry | Health Care (XLV) / Health Care Technology |
| S&P 500 rank (by weight) | #231 · 0.07% (Oct 30, 2026) |
| Sector rank | #29 in Health Care (Oct 30, 2026) |
| Headquarters | Pleasanton, California |
| Founded | 2007 |
| CEO | Peter Gassner (CEO) |
| Employees | 7,928 (2026) |
| Market cap | $50.67B (Oct 30, 2026) |
| Share price | $312.96 (Oct 30, 2026) |
| SEC filings | EDGAR — CIK 0001393052 |
WHAT IT DOES
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud software, data and consulting built only for the life sciences industry — pharmaceutical, biotechnology and medical-device companies, plus the contract research and sales organisations that serve them. It reported 1,552 customers in its fiscal 2026 annual report.
Its one-line model: sell industry-specific subscription software that manages drug development and drug selling — clinical trials, regulatory submissions, quality, safety and commercial CRM — and charge for the implementation and consulting that embeds it. Subscriptions were $2,684.2M of fiscal 2026 revenue, 84% of the total.
The economics are vertical-SaaS economics: one validated product release serves every customer, regulated records are costly to move, and land-and-expand across its four clouds lifts revenue per customer. Fiscal 2026 total revenues were $3,195.3M, up 16% year over year, with GAAP operating income of $916.4M.
BUSINESS SEGMENTS
| R&D Solutions — Veeva Development Cloud | Clinical, regulatory and safety application suites on the Veeva Vault platform (EDC, eTMF, CTMS, RTSM, RIM, Safety) — R&D Solutions together produced about 55% of fiscal 2026 total revenue. |
| R&D Solutions — Veeva Quality Cloud | Quality management, regulated documents, training and laboratory applications (QMS, QualityDocs) for manufacturing and product-release compliance. |
| Commercial Solutions — Veeva Commercial Cloud | Vault CRM, content, medical and engagement applications for sales, marketing and medical teams — Commercial Solutions produced about 45% of fiscal 2026 total revenue; its subscription revenue was $1,258M. |
| Veeva Data Cloud | Reference, deep, transaction and patient data and analytics (including Crossix) feeding commercial decisions across the other clouds. |
| Professional Services & Business Consulting | Implementation, configuration, managed services and consulting — fiscal 2026 professional services and other revenue of $511.1M, 16% of total revenue. |
R&D Solutions — Veeva Development Cloud Clinical, regulatory and safety application suites on the Veeva Vault platform (EDC, eTMF, CTMS, RTSM, RIM, Safety) — R&D Solutions together produced about 55% of fiscal 2026 total revenue.
R&D Solutions — Veeva Quality Cloud Quality management, regulated documents, training and laboratory applications (QMS, QualityDocs) for manufacturing and product-release compliance.
Commercial Solutions — Veeva Commercial Cloud Vault CRM, content, medical and engagement applications for sales, marketing and medical teams — Commercial Solutions produced about 45% of fiscal 2026 total revenue; its subscription revenue was $1,258M.
Veeva Data Cloud Reference, deep, transaction and patient data and analytics (including Crossix) feeding commercial decisions across the other clouds.
Professional Services & Business Consulting Implementation, configuration, managed services and consulting — fiscal 2026 professional services and other revenue of $511.1M, 16% of total revenue.
HISTORY
| Year | Milestone |
|---|---|
| 2007 | Veeva is founded in 2007 by Peter Gassner and Matt Wallach, on the thesis that life sciences needs purpose-built industry cloud software; its first product is a pharma CRM built on the Salesforce platform Gassner had helped build. |
| 2011 | Veeva introduces Veeva Vault in 2011, its own platform for regulated content and data management — the move that takes it beyond CRM into R&D. |
| 2013 | Veeva lists on the New York Stock Exchange in October 2013, one of the most successful software IPOs of its era. |
| 2019 | Veeva acquires Crossix, a privacy-safe patient data and analytics company, and Physicians World, a business-process outsourcing provider, in late 2019 — the data and services build-out behind Data Cloud. |
| 2021 | In February 2021 Veeva becomes the first publicly traded company to convert to a public benefit corporation. |
| 2025 | Veeva ends its partnership with Salesforce in 2025 as its CRM completes the migration to its own Vault platform, removing its original platform dependency. |
COMPETITIVE POSITION
FINANCIAL SNAPSHOT
| Total revenues | $3,195.3M (FY2026, year ended Jan 31, 2026) |
| Operating income | $916.4M (FY2026 operating income) |
| Net income | $908.9M (FY2026 net income) |
| Diluted EPS | $5.44 (FY2026 diluted EPS) |
KEY RISKS
WHY IT MATTERS FOR THE S&P 500
Veeva is a small-weight health-care constituent: rank #231 by weight at 0.07% as of Oct 30, 2026, and #29 in Health Care. As the index's pure-play life-sciences software company, it is the cleanest read on how drug makers digitise development and commercialisation — and on the durability of vertical SaaS pricing.
SOURCES & METHODOLOGY
| Financials, segments, headquarters | Veeva fiscal 2026 results release and Form 10-K data via company release, Wikipedia company profile and StockAnalysis (year ended January 31, 2026); headquarters, CEO and employees via Wikipedia company profile |
| Index weight & ranks | Slickcharts S&P 500 weights, Oct 30, 2026 close, fetched Nov 2, 2026 (dispatch baseline, used verbatim) |
| Market cap | $50.67B (Oct 30, 2026) |
| Logo | SPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. |
| Chart | SPXSet chart library, monthly bars, compiled from Yahoo public information. |
Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com
FINANCIALS
公司快照
| 股票代號 | VEEV |
| 公司 | Veeva Systems Inc.(Veeva) |
| GICS 板塊/行業 | 醫療保健(XLV)/醫療保健科技 |
| 標普500排名(按權重) | #231 · 0.07%(Oct 30, 2026) |
| 板塊內排名 | 醫療保健 #29(Oct 30, 2026) |
| 總部 | 美國加利福尼亞州普萊森頓 |
| 成立 | 2007年 |
| 執行長 | Peter Gassner(執行長) |
| 員工 | 7,928(2026年) |
| 市值 | $50.67B(Oct 30, 2026) |
| 股價 | $312.96(Oct 30, 2026) |
| SEC 申報 | EDGAR — CIK 0001393052 |
業務概覽
Veeva 總部位於加利福尼亞州普萊森頓,專為生命科學行業——製藥、生物科技與醫療器械公司,以及其外判研究與銷售機構——提供雲端軟件、數據與諮詢服務。公司 2026 財年年報披露客戶數為 1,552 家。
其一句話商業模式是:銷售專為行業而設的訂閱軟件,管理藥物研發與藥物銷售——臨床試驗、監管申報、品質、安全與商業 CRM——並就嵌入系統的實施與諮詢收費。訂閱收入 26.842 億美元,佔 2026 財年總收入的 84%。
其經濟學是垂直 SaaS 的經濟學:一套經驗證的產品版本服務所有客戶,受監管紀錄遷移成本高昂,而四大雲之間的交叉銷售提升每名客戶的收入。2026 財年總收入 31.953 億美元,按年增長 16%,GAAP 營業利潤 9.164 億美元。
業務板塊
| 研發解決方案 — Veeva Development Cloud | 建於 Veeva Vault 平台的臨床、監管與安全應用套件(EDC、eTMF、CTMS、RTSM、RIM、Safety)——研發解決方案合計約佔 2026 財年總收入的 55%。 |
| 研發解決方案 — Veeva Quality Cloud | 品質管理、受監管文件、培訓與實驗室應用(QMS、QualityDocs),支援生產與產品放行合規。 |
| 商業解決方案 — Veeva Commercial Cloud | 供銷售、市場與醫學團隊使用的 Vault CRM、內容、醫學與互動應用——商業解決方案約佔 2026 財年總收入的 45%,其訂閱收入為 12.58 億美元。 |
| Veeva Data Cloud | 參考、深度、交易與患者數據及分析(包括 Crossix),為其他雲的商業決策提供數據基礎。 |
| 專業服務與商業諮詢 | 實施、配置、託管服務與諮詢——2026 財年專業服務及其他收入 5.111 億美元,佔總收入 16%。 |
研發解決方案 — Veeva Development Cloud 建於 Veeva Vault 平台的臨床、監管與安全應用套件(EDC、eTMF、CTMS、RTSM、RIM、Safety)——研發解決方案合計約佔 2026 財年總收入的 55%。
研發解決方案 — Veeva Quality Cloud 品質管理、受監管文件、培訓與實驗室應用(QMS、QualityDocs),支援生產與產品放行合規。
商業解決方案 — Veeva Commercial Cloud 供銷售、市場與醫學團隊使用的 Vault CRM、內容、醫學與互動應用——商業解決方案約佔 2026 財年總收入的 45%,其訂閱收入為 12.58 億美元。
Veeva Data Cloud 參考、深度、交易與患者數據及分析(包括 Crossix),為其他雲的商業決策提供數據基礎。
專業服務與商業諮詢 實施、配置、託管服務與諮詢——2026 財年專業服務及其他收入 5.111 億美元,佔總收入 16%。
歷史沿革
| 年份 | 里程碑 |
|---|---|
| 2007 | Veeva 於 2007 年由 Peter Gassner 與 Matt Wallach 創立,主張生命科學需要專門的行業雲軟件;首個產品是建於 Gassner 曾參與開發的 Salesforce 平台上的製藥 CRM。 |
| 2011 | Veeva 於 2011 年推出 Veeva Vault——自家的受監管內容與數據管理平台——由此走出 CRM、進入研發領域。 |
| 2013 | Veeva 於 2013 年 10 月在紐約證券交易所上市,是其年代最成功的軟件 IPO 之一。 |
| 2019 | Veeva 於 2019 年底收購隱私安全患者數據與分析公司 Crossix 及業務流程外判商 Physicians World,構成 Data Cloud 背後的數據與服務佈局。 |
| 2021 | 2021 年 2 月,Veeva 成為首家轉為公益公司(public benefit corporation)的上市公司。 |
| 2025 | Veeva 於 2025 年結束與 Salesforce 的合作,其 CRM 完成向自家 Vault 平台的遷移,消除原有的平台依賴。 |
競爭地位
財務快照
| 總收入 | $3,195.3M(FY2026,截至 2026 年 1 月 31 日) |
| 營業利潤 | $916.4M(FY2026 營業利潤) |
| 淨利潤 | $908.9M(FY2026 淨利潤) |
| 稀釋 EPS | $5.44(FY2026 稀釋 EPS) |
主要風險
對標普500的重要性
Veeva 是權重較小的醫療保健成分股:按權重排名 #231,權重 0.07%(以 Oct 30, 2026 為準),醫療保健板塊內排名 #29。作為指數中純粹的生命科學軟件公司,它是觀察藥企如何把研發與商業化數碼化、以及垂直 SaaS 定價耐久性的最清晰指標。
來源與方法
| 財務、板塊、總部 | Veeva 2026 財年業績公告與 Form 10-K 數據,經公司公告、維基百科公司資料與 StockAnalysis(截至 2026 年 1 月 31 日);總部、執行長與員工經維基百科公司資料 |
| 指數權重與排名 | Slickcharts S&P 500 權重,Oct 30, 2026 收盤,Nov 2, 2026 抓取(派工基線,原文引用) |
| 市值 | $50.67B(Oct 30, 2026) |
| Logo | SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。 |
| 股價圖 | SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。 |
來源:Yahoo Finance 月線(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份)· SPXSet.com
財報
SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。
Entered 2026-11-01 19:26 · updated 2026-11-15 00:12 · rev 5